AUROBINDO PHARMA LTD. - 524804 - Intimation Of Demise Of Mr. Sanjeev I Dani, Chief Operating Officer (Formulations)
Intimation of demise of Mr. Sanjeev I Dani, Chief Operating Officer - Formulations, of the Company21-11-2023
21-11-2023
Aurobindo Pharma share price rises more than 1% on regulatory clearance of manufacturing facilities
Stock Market today- Share price of Aurobindo Pharma gained as regulatory clearance of plants lifted sentiments. The US sales contribute more than half to Aurobindo's sales and compliance of manufacturing units to the norms laid by the US drug regulator on good manufacturing practices is important.20-11-2023
Aurobindo Pharma hits 52-week high on US FDA clean chit to Telangana unit
Broking house Sharekhan in its November 13 report has has upgraded the stock to buy with a revised price target of Rs 1,163.20-11-2023
Accumulate Aurobindo Pharma; target of Rs 1065: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1065 in its research report dated November 11, 2023.18-11-2023
AUROBINDO PHARMA LTD. - 524804 - Completion Of US FDA Inspection At Unit I & III Of APL Healthcare Ltd., A Wholly Owned Subsidiary
Completion of US FDA Inspection at Unit I & III of APL Healthcare Lid., a wholly owned subsidiary with zero observations and No Action Indicated.17-11-2023
Neutral Aurobindo Pharma; target of Rs 970: Motilal Oswal
Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 970 in its research report dated November 11, 2023.16-11-2023
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Company officials will participate in the investor group meeting on 21st November 2023, arranged by JP Morgan16-11-2023
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q2FY24 Earnings Call held on November 10, 202315-11-2023
AUROBINDO PHARMA LTD. - 524804 - Resignation Of Mr.Venkat Nageswar, Independent Director Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary Of The Company
Resignation of Mr. Venkat Nageswar, Independent Director of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company14-11-2023
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company Officials are participating in investor group meetings from November 21, 2023 to November 24, 2023.14-11-2023